Anika Therapeutics: Q4 Earnings Insights

2024-03-14 04:40

Anika Therapeutics (NASDAQ:ANIK) reported its Q4 earnings results on Wednesday, March 13, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Anika Therapeutics beat estimated earnings by 119.0%, reporting an EPS of $0.05 versus an estimate of $-0.26.

Revenue was up $3.35 million from the same period last year.

Last quarter the company beat on EPS by $0.37 which was followed by a 11.0% increase in the share price the next day.

Here's a look at Anika Therapeutics's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.37	-0.27	-0.30	-0.24
EPS Actual	0	0.06	-0.36	-0.21
Revenue Estimate	38.27M	40.56M	37.28M	37.70M
Revenue Actual	41.47M	44.30M	37.92M	39.62M

To track all earnings releases for Anika Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.